152 / 172
152
72.Marmor MF, Kellner U, Lai TY, Lyons JS, Mieler WF;
American
Academy
of
Ophthalmology.
Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.Ophthalmology
2011;118:415-22.
73. Caporali R, Conti F, Alivernini S, Atzeni F, Seriolo B,
Cutolo M, et al. Recommendations for the use of biologic
therapy in rheumatoid arthritis: update from the Italian
Society for Rheumatology I. Efficacy. Clin Exp Rheumatol
2011;29:S7-14.
74. Favalli EG, Caporali R, Sinigaglia L, Pipitone N, Miniati I,
Montecucco C, et al. Recommendations for the use of biologic
therapy in rheumatoid arthritis: update from the Italian
Society for Rheumatology II. Safety. Clin Exp Rheumatol
2011;29:S15-27.
75.Markatseli TE, Papagoras C, Drosos AA. Prognostic factors
for
erosive
rheumatoid
arthritis. Clin
Exp
Rheumatol
2010;28:114-23.
76. Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas
D, Burmester G, et al. Treating rheumatoid arthritis to target:
recommendations of an international task force. Ann Rheum
Dis 2010;69:631-7.
77. Visser K, Katchamart W, Loza E, Martinez-Lopez JA, Salliot
C, Trudeau J, et al. Multinational evidence-based
recommendations for the use of methotrexate in rheumatic
disorders with a focus on rheumatoid arthritis: integrating
systematic literature research and expert opinion of a broad
international panel of rheumatologists in the 3E Initiative. Ann
Rheum Dis 2009;68:1086-93.
78. Momohara S, Inoue E, Ikari K, Yano K, Tokita A, Honjo Y,
et al. Comparison of characteristics and therapeutic efficacy in
rheumatoid arthritis patients treated by rheumatologists and
those treated by orthopedic surgeons under a team medicine